אירוע קליני
Medical Breakthroughs from ASCO
How will tamoxifen usage affect you? For how long will you need to be on chemotherapy? Will immunotherapy be an option if you have triple negative breast cancer? What new options are there for recurrent ovarian cancer? Could PARP inhibitors be an option for you?
Join us as our experts share the latest research updates you need to bring to your medical team.
Dr. Ruth Oratz, Medical Oncologist at Perlmutter Cancer Center, NYU Langone, and
Dr. Sharyn Lewin, Gynecologic Oncologist, Medical Director of the Division of Gynecologic Oncology,
המרכז הרפואי שם קדוש, will report on the latest updates and research you need to know from the American Society of Clinical Oncology’s annual virtual meeting.
לִרְשׁוֹם Here
וובינר זה התאפשר הודות לתמיכה נדיבה של:
קרן ההנצחה על שם זיגמונד ואדית בלומנטל
הסכם שיתוף הפעולה DP14-1408 מהמרכזים לבקרת מחלות ומניעתן